Chimeric microtubule disruptors†
Abstract
A chimeric approach is used to discover
* Corresponding authors
a
Medicinal Chemistry & Sterix Ltd., Department of Pharmacy & Pharmacology, University of Bath, Claverton Down, Bath, UK
E-mail:
B.V.L.Potter@bath.ac.uk
Fax: +44 (0)1225-386114
Tel: +44 (0)1225-386639
b Department of Biology & Biochemistry, University of Bath, Claverton Down, Bath, UK
c Department of Endocrinology & Metabolic Medicine & Sterix Ltd., Imperial College London, St Mary's Hospital, London W2 1NY, UK
d Institut de Recherche Henri Beaufour, 91966 Les Ulis Cedex, France
A chimeric approach is used to discover
M. P. Leese, F. Jourdan, M. R. Kimberley, G. E. Cozier, N. Thiyagarajan, C. Stengel, S. Regis-Lydi, P. A. Foster, S. P. Newman, K. R. Acharya, E. Ferrandis, A. Purohit, M. J. Reed and B. V. L. Potter, Chem. Commun., 2010, 46, 2907 DOI: 10.1039/C002558E
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content